Authors: BEVERIDGE RA MILLER JA KALES AN BINDER RA ROBERT NJ HARVEY JH WINDSOR K GORE I CANTRELL J THOMPSON KA TAYLOR WR BARNES HM SCHIFF SA SHIELDS JA CAMBARERI RJ BUTLER TP MEISTER RJ FEIGERT JM NORGARD MJ MORAES MA HELVIE WW PATTON GA MUNDY LJ HENRY D MASON B STADDON A FORD P KATCHER D HOUCK W MAJOR WB GEMMA NW KAY G PRIEST E SOWROY P BANK B LEIBACH S REISEL H GRAD G WARREN RD UENO WM SMITH LF DOBRZYNSKI RF SHERIDAN MJ

Citation: Ra. Beveridge et al., A COMPARISON OF EFFICACY OF SARGRAMOSTIM (YEAST-DERIVED RHUGM-CSF) AND FILGRASTIM (BACTERIA-DERIVED RHUG-CSF) IN THE THERAPEUTIC SETTING OFCHEMOTHERAPY-INDUCED MYELOSUPPRESSION, Cancer investigation, 16(6), 1998, pp. 366-373

Authors: BEVERIDGE RA MILLER JA KALES AN BINDER RA ROBERT NJ HEISRATHEVANS J KOCZYKSCRIPKA K PASHKO S NORGARD MJ BARNES HM TAYLOR WR THOMPSON KA SMITH LF UENO WM DOBRZYNSKI RF WARREN RD KATCHER D BYRNE PJ DUNNING DM WINOKUR SH LOCKEY JL CAMBARERI RJ BUTLER TP MEISTER RJ FIEGERT JM

Citation: Ra. Beveridge et al., RANDOMIZED TRIAL COMPARING THE TOLERABILITY OF SARGRAMOSTIM (YEAST-DERIVED RHUGM-CSF) AND FILGRASTIM (BACTERIA-DERIVED RHUG-CSF) IN CANCER-PATIENTS RECEIVING MYELOSUPPRESSIVE CHEMOTHERAPY, Supportive care in cancer, 5(4), 1997, pp. 289-298